Rivastigmins hæmning af butyrylcholinesterase- aktivitet i CSF hos 14 patienter med Alzheimer var sammenlignelig med hæmningen af AChE.
Inhibition of butyrylcholinesterase activity in CSF of 14 Alzheimer patients treated by rivastigmine was similar to that of AChE.